Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Irritable Bowel Syndrome

  Free Subscription


13.04.2026

1 Biochem Pharmacol
1 bioRxiv
1 BMJ Case Rep
1 Brain Imaging Behav
1 Commun Med (Lond)
1 Curr Protein Pept Sci
1 Front Immunol
3 Front Med (Lausanne)
1 Gastro Hep Adv
3 J Neurogastroenterol Motil
1 JGH Open
2 Neurogastroenterol Motil
1 Res Sq
1 Saudi J Gastroenterol
1 Ther Adv Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Biochem Pharmacol

  1. ISHIOH M, Nozu T, Ohgidani M, Furube E, et al
    beta-Hydroxybutyrate modulates intestinal barrier function and visceral sensitivity via a brain AMPK-orexin pathway recruiting histamine H1 receptors, basal forebrain cholinergic neurons, adenosine A2B receptors, and vagal output in rats.
    Biochem Pharmacol. 2026;250.
    PubMed         Abstract available


    bioRxiv

  2. MULLER E, Baum S, Borenstein E
    MAAMOUL: Metabolic network-based discovery of microbiome-metabolome shifts in disease.
    bioRxiv [Preprint]. 2026 Mar 30:2026.03.27.714614.
    PubMed         Abstract available


    BMJ Case Rep

  3. HEBDEN LA, Sreh A, Hebden JM
    Functional bowel disease symptoms and a de novo raised carcinoembryonic antigen: delayed diagnosis of medullary cell thyroid carcinoma.
    BMJ Case Rep. 2026;19:e270871.
    PubMed         Abstract available


    Brain Imaging Behav

  4. REISIAN M, Toben C, Ciobanu LG, Jawahar MC, et al
    A systematic review of associations between functional connectivity, mood and cognition in patients with irritable bowel syndrome.
    Brain Imaging Behav. 2026;20:71.
    PubMed         Abstract available


    Commun Med (Lond)

  5. MEHRAVAR S, Yeo YH, Pimentel M, Naji P, et al
    Association of pharmacotherapy with all-cause mortality among patients with irritable bowel syndrome.
    Commun Med (Lond). 2026;6:176.
    PubMed         Abstract available


    Curr Protein Pept Sci

  6. THOMBRE KR, Rahangdale ND, Gupta KR, Umekar MJ, et al
    Neuropeptide Y Receptor Modulators in Gut Physiology and Therapy.
    Curr Protein Pept Sci. 2026 Mar 18. doi: 10.2174/0113892037432130260204153437.
    PubMed         Abstract available


    Front Immunol

  7. EL-SAADONY MT, Saad AM, Sitohy M, Alkafaas SS, et al
    Probiotics and human health: biological activities, nutritional aspects, immunomodulatory properties, applications, and future perspectives - a comprehensive review.
    Front Immunol. 2026;16:1713426.
    PubMed         Abstract available


    Front Med (Lausanne)

  8. TIAN D, Liu X, Qiao H, Liu F, et al
    Map the prevalence of irritable bowel syndrome across China: a systematic review and meta-analysis.
    Front Med (Lausanne). 2026;13:1740952.
    PubMed         Abstract available

  9. LI S, Dong W, Chen X, Tan X, et al
    Association between ultra-processed food consumption and risk of irritable bowel syndrome and functional dyspepsia: a systematic review and meta-analysis of observational studies.
    Front Med (Lausanne). 2026;13:1780040.
    PubMed         Abstract available

  10. XU C, Shi Y, Huang W, Zhuang H, et al
    Cultural adaptation and psychometric validation of the Gastrointestinal Unhelpful Thinking Scale.
    Front Med (Lausanne). 2026;13:1807329.
    PubMed         Abstract available


    Gastro Hep Adv

  11. PELLETIER K, Villarreal M, Klar R, Chey WD, et al
    Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Reintroduction in Clinical Practice: Surveying the Gaps and Opportunities.
    Gastro Hep Adv. 2026;5:100908.
    PubMed         Abstract available


    J Neurogastroenterol Motil

  12. LI C, Liu Q, Cao J, Xu X, et al
    Patients' Knowledge, Attitudes, and Practices Regarding Non-pharmacological Treatments for Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2026;32:276-289.
    PubMed         Abstract available

  13. EL-SALHY M, Corsetti M, Gilja OH, Gonlachanvit S, et al
    Towards a Standard Protocol for Fecal Microbiota Transplantation in Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2026;32:185-197.
    PubMed         Abstract available

  14. KIM JW
    From Belief to Behavior: Closing the Knowledge-Practice Gap in Irritable Bowel Syndrome Self-management.
    J Neurogastroenterol Motil. 2026;32:145-147.
    PubMed        


    JGH Open

  15. NISHIDA T, Osugi N, Amano T, Yoshihara T, et al
    Selective Drug-Free Active Surveillance in Ulcerative Colitis: Biomarker-Guided, Patient-Centered Approach.
    JGH Open. 2026;10:e70399.
    PubMed         Abstract available


    Neurogastroenterol Motil

  16. WUESTENBERGHS F, Jouet P, Piche T, Mion F, et al
    Impact of Early-Onset IBS on Schooling, Illness in Adulthood, and Career Prospects.
    Neurogastroenterol Motil. 2026;38:e70308.
    PubMed         Abstract available

  17. KULIN D, Shah A, Fairlie T, Staller K, et al
    Gastrointestinal Symptoms and Systemic Comorbidities in Patients With POTS: A Systematic Review and Meta-Analysis.
    Neurogastroenterol Motil. 2026;38:e70305.
    PubMed         Abstract available


    Res Sq

  18. AZIZ NI, Rahim A, Azam SI, Butt AS, et al
    Frequency of Functional Gastrointestinal Disorders and association with occupational stress among nurses at a tertiary care hospital in Karachi, Pakistan: an analytical cross-sectional study.
    Res Sq [Preprint]. 2026 Apr 1:rs.3.rs-9219713. doi: 10.21203/rs.3.rs-9219713.
    PubMed         Abstract available


    Saudi J Gastroenterol

  19. ALZAHRANI MA, Alzubide SR, Abufarhaneh E, Alqaraawi AM, et al
    Saudi consensus statements on the management of irritable bowel syndrome.
    Saudi J Gastroenterol. 2026 Apr 8. doi: 10.4103.
    PubMed         Abstract available


    Ther Adv Gastroenterol

  20. WEI Y, Shi Z, Wu S, Yao X, et al
    Efficacy and safety of non-invasive transcutaneous nerve stimulation in patients with irritable bowel syndrome: a systematic review and meta-analysis.
    Ther Adv Gastroenterol. 2026;19:17562848261436121.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum